RU2123847C1 - Лекарственное средство и способ лечения повышенного глазного давления и/или глаукомы - Google Patents

Лекарственное средство и способ лечения повышенного глазного давления и/или глаукомы Download PDF

Info

Publication number
RU2123847C1
RU2123847C1 RU96121253A RU96121253A RU2123847C1 RU 2123847 C1 RU2123847 C1 RU 2123847C1 RU 96121253 A RU96121253 A RU 96121253A RU 96121253 A RU96121253 A RU 96121253A RU 2123847 C1 RU2123847 C1 RU 2123847C1
Authority
RU
Russia
Prior art keywords
group
formula
lower alkyl
alkyl group
hydrogen atom
Prior art date
Application number
RU96121253A
Other languages
English (en)
Russian (ru)
Other versions
RU96121253A (ru
Inventor
Йокояма Томихиза
Хосокава Цунемити
Янагисава Хирояки
Original Assignee
Санкио Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санкио Компани Лимитед filed Critical Санкио Компани Лимитед
Application granted granted Critical
Publication of RU2123847C1 publication Critical patent/RU2123847C1/ru
Publication of RU96121253A publication Critical patent/RU96121253A/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RU96121253A 1994-03-16 1995-03-16 Лекарственное средство и способ лечения повышенного глазного давления и/или глаукомы RU2123847C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6/45404 1994-03-16
JP4540494 1994-03-16

Publications (2)

Publication Number Publication Date
RU2123847C1 true RU2123847C1 (ru) 1998-12-27
RU96121253A RU96121253A (ru) 1999-01-20

Family

ID=12718322

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96121253A RU2123847C1 (ru) 1994-03-16 1995-03-16 Лекарственное средство и способ лечения повышенного глазного давления и/или глаукомы

Country Status (20)

Country Link
US (1) US5925664A (enExample)
EP (2) EP0795326B1 (enExample)
KR (1) KR100211446B1 (enExample)
CN (2) CN1104898C (enExample)
AT (2) ATE266402T1 (enExample)
AU (1) AU684916B2 (enExample)
CZ (1) CZ284395B6 (enExample)
DE (2) DE69533045T2 (enExample)
DK (2) DK0795326T3 (enExample)
ES (2) ES2221872T3 (enExample)
FI (2) FI114897B (enExample)
GR (1) GR3036989T3 (enExample)
HK (1) HK1000551A1 (enExample)
HU (1) HUT74734A (enExample)
MX (1) MX9604109A (enExample)
NO (1) NO311068B1 (enExample)
NZ (1) NZ282485A (enExample)
PT (2) PT1110551E (enExample)
RU (1) RU2123847C1 (enExample)
WO (1) WO1995024902A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201466A3 (en) * 1999-06-11 2003-04-28 Sankyo Co Ocular tension lowering composition for topical administration
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
WO2002045748A1 (en) * 2000-12-05 2002-06-13 Sankyo Company, Limited Ocular tension-lowering compositions for topical administration
ES2535291T3 (es) * 2003-04-15 2015-05-08 Daiichi Sankyo Company, Limited Medoxomilo de olmesartán para prevención o tratamiento de enfermedades oculares angiogénicas

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000366A1 (fr) * 1983-07-13 1985-01-31 Laboratoires Chauvin-Blache Nouvelles amidines, leur procede de preparation et leur application en therapeutique
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
EP0380959A1 (en) * 1989-01-19 1990-08-08 E.I. Du Pont De Nemours And Company Combination beta-Blocking/angiotensin II blocking antihypertensives
EP0535463A1 (de) * 1991-10-01 1993-04-07 Bayer Ag Imidazolyl-propensäurederivate als Angiotensin II Antagonisten

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
ZA875052B (en) * 1986-07-11 1989-03-29 Du Pont Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
AU644802B2 (en) * 1989-06-30 1993-12-23 E.I. Du Pont De Nemours And Company Substituted imidazoles
WO1991015206A1 (en) * 1990-04-05 1991-10-17 E.I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
CA2229000C (en) * 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
ATE199548T1 (de) * 1992-06-02 2001-03-15 Sankyo Co 4-carboxyimidazolderivate als angiotensin-ii- antagonisten und ihre therapeutische verwendung
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
HU219598B (hu) * 1992-12-17 2001-05-28 Sankyo Co. Ltd. Bifenilvegyületek imidazol- és piridinszármazékai, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
WO1995021609A1 (en) * 1994-02-08 1995-08-17 Ciba-Geigy Ag Treatment of normotensive glaucoma with angiotensin ii antagonists

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000366A1 (fr) * 1983-07-13 1985-01-31 Laboratoires Chauvin-Blache Nouvelles amidines, leur procede de preparation et leur application en therapeutique
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
EP0380959A1 (en) * 1989-01-19 1990-08-08 E.I. Du Pont De Nemours And Company Combination beta-Blocking/angiotensin II blocking antihypertensives
EP0535463A1 (de) * 1991-10-01 1993-04-07 Bayer Ag Imidazolyl-propensäurederivate als Angiotensin II Antagonisten

Also Published As

Publication number Publication date
CZ269496A3 (en) 1996-12-11
GR3036989T3 (en) 2002-01-31
HU9602534D0 (en) 1996-11-28
DE69522955T2 (de) 2002-05-29
AU684916B2 (en) 1998-01-08
KR100211446B1 (ko) 1999-08-02
DK0795326T3 (da) 2001-11-26
NO963854D0 (no) 1996-09-13
NZ282485A (en) 1997-06-24
ES2163501T3 (es) 2002-02-01
FI20041236L (fi) 2004-09-24
EP1110551B1 (en) 2004-05-12
ATE266402T1 (de) 2004-05-15
DE69533045D1 (de) 2004-06-17
HUT74734A (en) 1997-02-28
NO311068B1 (no) 2001-10-08
KR970701542A (ko) 1997-04-12
DK1110551T3 (da) 2004-06-07
FI114897B (fi) 2005-01-31
FI963645A7 (fi) 1996-11-14
PT795326E (pt) 2002-01-30
DE69533045T2 (de) 2005-01-27
CN1104898C (zh) 2003-04-09
EP1110551A3 (en) 2001-08-16
AU1960295A (en) 1995-10-03
FI963645A0 (fi) 1996-09-16
US5925664A (en) 1999-07-20
EP1110551A2 (en) 2001-06-27
MX9604109A (es) 1997-09-30
HK1000551A1 (en) 2002-04-12
EP0795326A1 (en) 1997-09-17
CZ284395B6 (cs) 1998-11-11
CN1148809A (zh) 1997-04-30
WO1995024902A1 (en) 1995-09-21
ATE206050T1 (de) 2001-10-15
EP0795326B1 (en) 2001-09-26
EP0795326A4 (enExample) 1997-09-17
CN1202819C (zh) 2005-05-25
ES2221872T3 (es) 2005-01-16
FI115197B (fi) 2005-03-31
DE69522955D1 (de) 2001-10-31
PT1110551E (pt) 2004-07-30
CN1387846A (zh) 2003-01-01
NO963854L (no) 1996-11-14

Similar Documents

Publication Publication Date Title
EP1234582B1 (en) Concomitant drugs for treating glaucoma
RU2123847C1 (ru) Лекарственное средство и способ лечения повышенного глазного давления и/или глаукомы
HK1000551B (en) Ocular tension depressant
CA2185524C (en) Ocular tension depressant
CA2376780C (en) Intraocular tension lowering compositions for topical administration
JP2826077B2 (ja) 眼圧低下剤
JP4132798B2 (ja) 局所投与のための眼圧低下組成物
HK1035485B (en) Ocular tension lowering agent
HK1035485A1 (en) Ocular tension lowering agent
JP3790093B2 (ja) 局所投与用眼圧低下組成物
HK1042050B (en) Ocular tension lowering composition for topical adminstration
HK1055894A (en) Combined angiotensin ii antagonists and carbonic anhydrase inhibitors for treatment of glaucoma
HK1055684A (en) Combined angiotensin ii antagonists and adrenaline receptor blockers for treatment of glaucoma